Related Experiment Videos
Progesterone-dependent immunomodulation.
J Szekeres-Bartho1, B Polgar, N Kozma
1Department of Medical Microbiology and Immunology, Pecs University, Medical School, Pecs, Hungary.
Chemical Immunology and Allergy
|September 1, 2005
Summary
Progesterone-induced blocking factor (PIBF) is crucial for successful pregnancy. Lower PIBF levels predict pregnancy termination, while PIBF treatment can correct pregnancy loss in mice.
Area of Science:
- Immunology
- Reproductive Biology
- Cell Biology
Background:
- Progesterone exerts biological effects via the progesterone-induced blocking factor (PIBF), a 34-kDa protein.
- PIBF is synthesized by lymphocytes during healthy pregnancy and modulates immune responses.
- PIBF influences arachidonic acid release, NK activity, and cytokine balance.
Purpose of the Study:
- To elucidate the biological functions and significance of PIBF in pregnancy.
- To investigate the role of PIBF in pregnancy outcomes and potential therapeutic applications.
Main Methods:
- Analysis of PIBF synthesis and cellular localization (centrosome association, secretion).
- Investigation of PIBF's effects on intracellular signaling pathways (STAT6, STAT4, PKC).
- Correlation of urinary PIBF concentrations with pregnancy outcomes in humans and resorption rates in mice.
Main Results:
- PIBF induces STAT6 nuclear translocation and PKC phosphorylation while inhibiting STAT4 phosphorylation.
- Urinary PIBF concentration correlates with pregnancy success; low levels predict premature termination.
- In vivo studies showed RU 486 treatment increased resorption rates due to impaired PIBF production, which was reversed by PIBF administration.
Conclusions:
- PIBF plays a critical role in maintaining pregnancy by modulating immune responses and intracellular signaling.
- PIBF levels serve as a predictive marker for pregnancy outcomes.
- PIBF demonstrates therapeutic potential for preventing pregnancy loss associated with immune dysregulation or progesterone receptor blockade.